A detailed history of Ranch Capital Advisors Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ranch Capital Advisors Inc. holds 12,649 shares of ABBV stock, worth $2.26 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
12,649
Previous 11,718 7.95%
Holding current value
$2.26 Million
Previous $2.01 Million 24.29%
% of portfolio
1.19%
Previous 1.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $152,535 - $185,576
931 Added 7.95%
12,649 $2.5 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $37,613 - $43,924
243 Added 2.12%
11,718 $2.01 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $23,173 - $26,404
145 Added 1.28%
11,475 $2.09 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $962,649 - $1.08 Million
6,996 Added 161.42%
11,330 $1.76 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $7,553 - $9,399
-57 Reduced 1.3%
4,334 $583,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $19,233 - $22,149
-133 Reduced 2.94%
4,391 $699,000
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $268 - $307
2 Added 0.04%
4,524 $607,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $10,046 - $12,772
-73 Reduced 1.59%
4,522 $693,000
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $263 - $327
2 Added 0.04%
4,595 $745,000
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $88,522 - $112,006
824 Added 21.86%
4,593 $622,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $10,959 - $12,440
103 Added 2.81%
3,769 $407,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $8,416 - $9,376
-80 Reduced 2.14%
3,666 $412,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $1,227 - $1,351
12 Added 0.32%
3,746 $405,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $21,651 - $29,232
269 Added 7.76%
3,734 $400,000
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $14,003 - $16,435
163 Added 4.94%
3,465 $303,000
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $4,475 - $5,988
61 Added 1.88%
3,302 $305,000
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $7,546 - $11,441
-117 Reduced 3.48%
3,241 $246,000
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $9,449 - $11,822
-131 Reduced 3.75%
3,358 $297,000
Q3 2019

Nov 18, 2019

BUY
$62.98 - $75.72 $219,737 - $264,187
3,489 New
3,489 $264,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ranch Capital Advisors Inc. Portfolio

Follow Ranch Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.